December 2025
The U.S. live cell imaging market size is evaluated at USD 900 million in 2025 and is predicted to hit around USD 2,026.67 million by 2035, growing at a CAGR of 8.46%.
September 2026
The global live cell imaging market size is calculated at USD 3.56 billion in 2026 and is projected to hit around USD 7.22 billion by 2035 with a CAGR of 8.21%.
September 2026
The U.S. cell therapy manufacturing market was worth USD 1.97 billion in 2026, with key U.S. cell therapy manufacturing market players including Merck KGaA, Thermo Fisher Scientific, Catalent, Inc.
September 2026
The U.S. CAR T-cell therapy market size stood at USD 2,684.84 million in 2026, with major U.S. CAR T-cell therapy market companies including Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences, Inc.
July 2026
The cell and gene therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
June 2026
The U.S. stem cell therapy market size reached USD 6.75 billion in 2025 and is projected to hit around USD 21.31 billion by 2035 with a remarkeble CAGR of 12.18%.
April 2026
The U.S. imaging services market size is expected to increase from USD 154.11 billion in 2025 and is projected to hit around USD 250.10 billion by 2035 with a CAGR of 4.96%.
December 2025
The U.S. cellulose acetate market size is evaluated at USD 1.76 billion in 2025 and is predicted to hit around USD 2.79 billion by 2035, growing at a CAGR of 4.72%.
September 2026
The cell therapy market size reached USD 9.13 billion in 2026, with leading cell therapy market companies including cell therapy , Cells for Cells, Celgene Corporation.
September 2026
The global medical imaging market size is calculated at USD 54.70 billion in 2026 and is projected to hit around USD 84.07 billion by 2035 with a notable CAGR of 4.90%.
September 2026
The RNA interference drug delivery market was worth USD 139.58 billion in 2026, with key RNA interference drug delivery market players including Dicerna Pharmaceuticals (Acquired by Novo Nordisk), Silence Therapeutics, Ionis Pharmaceuticals.
September 2026
The quantum sensing medical imaging market reached USD 370.11 million in 2026, with key quantum sensing medical imaging market companies including Qnami, Quantum Diamond Technologies Inc. (QDTI).
September 2026
The global quantum-assisted imaging reconstruction market is advancing with the integration of quantum computing for ultra-fast, high-resolution image processing.
September 2026
The global minimally invasive medical imaging market explores global forecasts, key regional dynamics and how imaging advances are reshaping minimally invasive clinical workflows
September 2026
The last-mile delivery transportation market size is calculated at USD 203.36 billion in 2026 and is expected to hit around USD 487.20 billion by 2035, with a CAGR of 10.12%.
September 2026
The fuel cell electric vehicle market size reached USD 19.24 billion in 2026, with leading fuel cell electric vehicle market companies including Honda Motor Co., Ltd., Hyundai Motor Company, Toyota Motor Corporation.
September 2026
The stem cell therapy market size is expected to increase from USD 20.53 billion in 2026 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
September 2026
The global dye sensitized solar cell market size was evaluated at USD 203.20 million in 2026 and is predicted to attain around USD 512.92 million by 2034, with a CAGR of 12.26%.
September 2026
The solid oxide fuel cell market size was calculated at USD 4.87 billion in 2026 and is projected to reach around USD 32.14 billion by 2034 with a CAGR of 26.60%.
September 2026
The U.S. pharmaceutical CDMO market size was calculated at USD 46.55 billion in 2026 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
September 2026
The extraoral imaging market size was estimated at USD 1.08 billion in 2026 and is expected to surge around USD 1.90 billion by 2034, with a CAGR of 7.34%.
September 2026
The global cell encapsulation technology market is growing as regenerative medicine and cell therapies adopt protective encapsulation techniques.
September 2026
The global in vivo cell reprogramming market is expanding as regenerative medicine advances toward direct in-body cell conversion for tissue repair and disease treatment.
September 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
September 2026
The global peripheral blood mononuclear cells market size was evaluated at USD 350.42 billion in 2026 and is predicted to hit around USD 842.89 billion by 2035, growing at a CAGR of 10.26%.
September 2026
The global subcutaneous drug delivery devices market size was valued at USD 38.87 billion in 2026 and is projected to hit around USD 74.66 billion by 2035 with a CAGR of 7.53%.
September 2026
The pulmonary drug delivery systems market size reached USD 61.03 billion in 2026, with leading pulmonary drug delivery systems market companies including Philips Respironics, GlaxoSmithKline PLC, BoehringerIngelheim GmbH.
September 2026
The global medical supply delivery service market size is projected to hit around USD 143.89 billion by 2035 from USD 74.86 billion in 2026 with a CAGR of 7.44%.
September 2026
The U.S. hospital emergency department market is estimated to hit around USD 307.63 billion by 2035 increasing from USD 190.70 billion in 2026, with a CAGR of 5.44%.
September 2026
The global topical drug delivery market size was valued at USD 148.81 billion in 2026 and is expected to hit around USD 324.67 billion by 2035, growing at a CAGR of 9.06%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com